Skip to main content
logo
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
7.85
+0.03 (0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
7.85
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT

Ginkgo Bioworks Holdings Revenue

In the year 2025, Ginkgo Bioworks Holdings had annual revenue of $170.16M, down -25.06%. Ginkgo Bioworks Holdings had revenue of $33.40M in the quarter ending December 31, 2025, a decrease of -23.84%.

Revenue (ttm)
$170.16M
Revenue Growth
-25.06%
P/S Ratio
2.69
Revenue / Employee
$350,835
Employees
485
Market Cap
456.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025170.16M-56.89M-25.06%
Dec 31, 2024227.04M-24.41M-9.71%
Dec 31, 2023251.46M-226.25M-47.36%
Dec 31, 2022477.71M163.87M52.21%
Dec 31, 2021313.84M237.18M309.40%
Dec 31, 202076.66M22.47M41.48%
Dec 31, 201954.18M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
REGENXBIO170.44M
Assembly Biosciences72.30M
Entrada Therapeutics25.42M
Prelude Therapeutics12.14M
Ovid Therapeutics7.25M
Revenue Rankings

DNA News

More News